Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Revolution Medicines (NASDAQ:RVMD) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Survey
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Now Rated “Moderate Buy” by Wall Street Analysts
Krystal Biotech Analyst Says Stock Weakness 'Overblown'
Krystal Biotech, Inc. (KRYS) Q3 2026 Earnings Call Transcript
Krystal Biotech, Inc. (KRYS) Surpasses Q3 Earnings and Revenue Estimates
Nasdaq Rallies as Tech Stocks Recover From Friday's Selloff
Krystal Biotech Q3 Earnings Call Highlights
Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
Analysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out for
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome
Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
2,490 Shares in Krystal Biotech, Inc. $KRYS Purchased by Terra Nova Asset Management LLC
Krystal Biotech: My Analysis Suggests Stock Has Not Yet Reached Peak Value
Breakfast News: Week in Review
Breakfast News: 10 Moves to Fatten Your Nest Egg
Corient Private Wealth LP Grows Stock Position in Krystal Biotech, Inc. $KRYS
Hsbc Holdings PLC Invests $3.65 Million in Krystal Biotech, Inc. $KRYS
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference